Propel Antibody-Drug Conjugate Therapy Development with Clinical Trial Ready Immunohistochemistry Assays   Good Antibody-drug conjugate (ADC) therapy development decisions start with dependable research, and in the challenging, competitive pharmaceutical market, that means accurate, reliable testing protocols and results. In this webinar, Dr. Frank Lynch, EVP, Global Tissue Biomarker Services and Dr. Suso Platero, Chief Scientific Officer, […]

Join Discovery Life Sciences at the Applied Pharmaceutical Toxicology Conference APT 2023May 16-18 | San Francisco  | Genentech350 DNA Way, South San Francisco, CA 94080, Building 35, Conference Rooms 35-1A and 35-1B on the Upper Campus. Join our our Vendor Talk! Day 1, May 16, Session 1: 4:20-4:30p Marcela Alomia, Senior Director, ADME/Tox Title: ReachBio Acquired by Discovery Life […]

Join AllCells, A Discovery Life Sciences Company at ACTS 2023Sponsorship Information Coming Soon